kynurenine has been researched along with Fatigue Syndrome, Chronic in 3 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pathology of Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM) is currently under investigation, and the overlapping symptoms such as depression suggest that the CNS may be involved." | 5.62 | Kynurenine metabolites and ratios differ between Chronic Fatigue Syndrome, Fibromyalgia, and healthy controls. ( Fors, EA; Groven, N; Guzey, IC; Reitan, SK, 2021) |
| "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex and debilitating disease with a substantial social and economic impact on individuals and their community." | 2.82 | Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle? ( Annesley, SJ; Dehhaghi, M; Fisher, PR; Guillemin, GJ; Heng, B; Kavyani, B; Lidbury, BA; Missailidis, D; Schloeffel, R, 2022) |
| "The pathology of Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM) is currently under investigation, and the overlapping symptoms such as depression suggest that the CNS may be involved." | 1.62 | Kynurenine metabolites and ratios differ between Chronic Fatigue Syndrome, Fibromyalgia, and healthy controls. ( Fors, EA; Groven, N; Guzey, IC; Reitan, SK, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kavyani, B | 1 |
| Lidbury, BA | 1 |
| Schloeffel, R | 1 |
| Fisher, PR | 1 |
| Missailidis, D | 1 |
| Annesley, SJ | 1 |
| Dehhaghi, M | 1 |
| Heng, B | 1 |
| Guillemin, GJ | 1 |
| Rus, CP | 1 |
| de Vries, BEK | 1 |
| de Vries, IEJ | 1 |
| Nutma, I | 1 |
| Kooij, JJS | 1 |
| Groven, N | 1 |
| Reitan, SK | 1 |
| Fors, EA | 1 |
| Guzey, IC | 1 |
1 review available for kynurenine and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle?
Topics: Fatigue Syndrome, Chronic; Humans; Kynurenine; NAD | 2022 |
2 other studies available for kynurenine and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
Treatment of 95 post-Covid patients with SSRIs.
Topics: COVID-19; Fatigue Syndrome, Chronic; Humans; Kynurenine; Primary Dysautonomias; Selective Serotonin | 2023 |
Kynurenine metabolites and ratios differ between Chronic Fatigue Syndrome, Fibromyalgia, and healthy controls.
Topics: Adolescent; Adult; Case-Control Studies; Fatigue Syndrome, Chronic; Female; Fibromyalgia; Humans; Ky | 2021 |